T-cell Therapy Leads to Positive Response for Mesothelioma Patients
By: Devin Golden
August 10, 2023
A novel type of cancer cell and gene therapy performed well in a phase 1 clinical trial that consisted of patients with mesothelioma. The therapy, called gavocabtagene autoleucel,...
Read Post